To address these limitations, we aimed to construct and validate a predictive model integrating accessible clinical variables (age at onset, family history, dementia subtypes, neuropsychological assessments) with genetic risk indicators (APOE ε4 status) to estimate the likelihood of P/LP Variant carriage in patients with dementia and a positive family history. The gene discussed is APOE; the disease is dementia.